2021 MAY 07 (NewsRx) - By a News Reporter-Staff News Editor at Disease Prevention Daily - According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by the inventor VANDERVANTER, Donald (Puyallup, WA), filed on February 2, 2017, was made available online on April 22, 2021. The assignee for this patent application is Horizon Orphan LLC (Lake Forest, Illinois, United States). Reporters obtained the following quote from the background information supplied by the inventors: "Cystic fibrosis lung disease is characterized by chronic respiratory tract infection with multiple bacterial species frequently dominated by Pseudomonas aeruginosa, which has been associated with accelerated lung disease progression, increased morbidity, and decreased survival. Chronic Pseudomonas aeruginosa infection is typically treated with chronic inhaled antibiotics to suppress infection, reduce risk of pulmonary exacerbations, improve quality of life, and preserve lung function.
展开▼
